Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Samsung
Elon Musk
OnePlus
Realme
Motorola
iQOO
Poco
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Technology News / Microsoft launches new 'Plasma Bot' to help with COVID-19 treatment
Technology

Microsoft launches new 'Plasma Bot' to help with COVID-19 treatment

Microsoft launches new 'Plasma Bot' to help with COVID-19 treatment
Written by Shubham Sharma
Apr 21, 2020, 12:38 pm 3 min read
Microsoft launches new 'Plasma Bot' to help with COVID-19 treatment

In a bid to help with the treatment of the novel coronavirus disease, Microsoft has launched a new 'Plasma Bot'. The system works just like the automated symptom-checker of the company but focuses on determining your eligibility for donating plasma, which could ultimately help scientists devise a reliable convalescent plasma-based therapy for critical COVID-19 patients. Here's all about it.

Solution
Plasma therapy: Promising solution for COVID-19

The work on COVID-19 vaccines/drugs is going on, but it is not moving fast enough to match the spread of the virus, which is claiming thousands of lives daily. However, amid all this, the century-old convalescent plasma therapy, which involves transfusion of blood plasma from recovered patients, has shown promise, with mounting clinical evidence suggesting it could help COVID-19 patients get better quickly.

Plan
Now, Microsoft is helping with the development of plasma-based medicine

Owing to the growing evidence, Microsoft is now helping the CoVIg-19 Plasma Alliance - formed by leading biotech companies like Biotest, BPL, and LFB - develop a new "polyclonal hyperimmune globulin" plasma therapy. The method relies on blood plasma but instead of transfusing it directly into sick patients, it revolves around pooling multiple samples to concentrate the antibodies and create a reliable COVID-19 medication.

Bot
This is where Microsoft's new Plasma Bot comes in

To get the work on this medication started, Microsoft has launched the Plasma Bot as a way to collect samples from people who have recovered from COVID-19. The tool, accessible through the alliance website and eventually on web/social/search channels, throws a series of questions to determine if you qualify as a potential plasma donor and then directs you to the closest collection center.

Factors
Bot will consider various factors to determine eligibility

Notably, the questions put up by the Plasma Bot to determine donation eligibility will also include those around the person's medications for allergies and other conditions. This will help the company rule out unhealthy candidates and collect samples only from those who are healthy and have recovered completely from a COVID-19 infection, presumably with a high anti-body count.

Details
Developed treatment will have to go through human trials

Once sufficient samples from donors are collected, the medication will have to go through clinical trials to be approved for use on COVID-19 patients. "The sooner recovered COVID-19 patients donate convalescent plasma, the sooner the Alliance may be able to start manufacturing a potential therapy and begin clinical trials," the company said, adding that "these trials will determine if this therapy could treat patients."

Information
Other benefits of the new therapy

If successfully developed, Microsoft says, the new plasma-based medication could take less time to administer to patients. Additionally, it would also minimize the risk of any known virus or bacteria passing from donor to patient and promise a longer shelf-life for easy storage and shipping.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Shubham Sharma
Shubham Sharma
Twitter
Editor with over five years of experience in covering all things science, consumer tech, space tech, AI, infosec, and business. A commerce graduate from University of Lucknow. I have been handling Tech beat at NewsBytes since 2018.
Latest
Microsoft
Bangladesh Premier League
Coronavirus
COVID-19
Related
Latest
UK's new visa needs no job offer: Everything to know
UK's new visa needs no job offer: Everything to know World
J&K: Longest-surviving Hizbul Mujahideen terrorist among 3 killed in encounter
J&K: Longest-surviving Hizbul Mujahideen terrorist among 3 killed in encounter India
IPL 2022, GT vs MI: Hardik Pandya elects to field
IPL 2022, GT vs MI: Hardik Pandya elects to field Sports
5 delicious Mother's Day recipes to surprise your mom
5 delicious Mother's Day recipes to surprise your mom Lifestyle
IPL 2022, PBKS vs RR: Preview, stats, and Fantasy XI
IPL 2022, PBKS vs RR: Preview, stats, and Fantasy XI Sports
Microsoft
Epstein among 'many things' why divorce happened: Melinda French Gates
Epstein among 'many things' why divorce happened: Melinda French Gates World
Microsoft CEO Satya Nadella's son Zain Nadella dies at 26
Microsoft CEO Satya Nadella's son Zain Nadella dies at 26 Business
Microsoft Surface Laptop Studio debuts at Rs. 1.57 lakh
Microsoft Surface Laptop Studio debuts at Rs. 1.57 lakh Technology
Microsoft Surface Pro 8 debuts in India at Rs. 1,04,500
Microsoft Surface Pro 8 debuts in India at Rs. 1,04,500 Technology
Microsoft Surface Pro X launched in India at Rs. 94,000
Microsoft Surface Pro X launched in India at Rs. 94,000 Technology
More News
Bangladesh Premier League
2021-22 Bangladesh Premier League: All you need to know
2021-22 Bangladesh Premier League: All you need to know Sports
35% kids not receiving mid-day meals, says survey; UP worst
35% kids not receiving mid-day meals, says survey; UP worst India
IPL: KKR to sign USA's Ali Khan as Gurney's replacement
IPL: KKR to sign USA's Ali Khan as Gurney's replacement Sports
Gayle will be a part of KXIP's core group: Rahul
Gayle will be a part of KXIP's core group: Rahul Sports
Beds and Delhi: Heartbreaking stories debunk Arvind Kejriwal's claims
Beds and Delhi: Heartbreaking stories debunk Arvind Kejriwal's claims India
More News
Coronavirus
COVID-19: India logs 3,303 new cases; 39 more deaths
COVID-19: India logs 3,303 new cases; 39 more deaths India
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man
COVID-19 XE variant reported by Gujarat; detected in 67-year-old man India
COVID-19 vaccine precautionary dose available for 18+ from April 10
COVID-19 vaccine precautionary dose available for 18+ from April 10 India
COVID-19 survivors at risk of developing serious blood clots: Study
COVID-19 survivors at risk of developing serious blood clots: Study Technology
COVID-19: India reports 1,660 new cases, 4,100 more deaths
COVID-19: India reports 1,660 new cases, 4,100 more deaths India
More News
COVID-19
COVID-19: India logs 3,545 new cases, 27 more deaths
COVID-19: India logs 3,545 new cases, 27 more deaths India
Uttarakhand: Kedarnath Temple opens with daily limit on pilgrims
Uttarakhand: Kedarnath Temple opens with daily limit on pilgrims India
Asian Games 2022 postponed as China battles COVID-19 wave
Asian Games 2022 postponed as China battles COVID-19 wave Sports
WHO report claims India underreported COVID-19 deaths; India strongly objects
WHO report claims India underreported COVID-19 deaths; India strongly objects India
COVID-19: India reports 3,275 new cases, 55 more deaths
COVID-19: India reports 3,275 new cases, 55 more deaths India
More News
Related
Convalescent plasma therapy doesn't stop COVID-19 progression: NIH
Convalescent plasma therapy doesn't stop COVID-19 progression: NIH Technology
ICMR drops convalescent plasma therapy from COVID-19 treatment guidelines
ICMR drops convalescent plasma therapy from COVID-19 treatment guidelines India
'Irrational': Experts question plasma therapy, urge government to review guidelines
'Irrational': Experts question plasma therapy, urge government to review guidelines India
Next News Article
Next News Article

Love Technology news?

Subscribe to stay updated.

Science Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022